According to Amphastar Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 24.29%. At the end of 2022 the company had an Operating Margin of 23.26%.
Year | Operating Margin | Change |
---|---|---|
2022 | 23.26% | 20.99% |
2021 | 19.22% | 1350.08% |
2020 | 1.33% | -92.91% |
2019 | 18.68% | -654.65% |
2018 | -3.37% | -598.49% |
2017 | 0.68% | -88.46% |
2016 | 5.86% | -242.15% |
2015 | -4.12% | -52.21% |
2014 | -8.62% | -214.97% |
2013 | 7.50% | -40.78% |
2012 | 12.67% | -147.01% |
2011 | -26.94% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Tonix Pharmaceuticals TNXP | 0.00% | N/A | ๐บ๐ธ USA |
SCYNEXIS SCYX | -1,223.94% | -5,138.86% | ๐บ๐ธ USA |
Marinus Pharmaceuticals MRNS | -64.47% | -365.42% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | -451.32% | -1,958.05% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.